NeoGenomics (NEO)
(Real Time Quote from BATS)
$15.58 USD
-0.46 (-2.87%)
Updated Sep 9, 2024 01:14 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Revenue - Line of Business Segments | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|---|
Revenue: Clinical Services [$M] |
-- | 496 | 419 | 404 | 382 | 361 |
Revenue: Advanced Diagnostics [$M... |
-- | 96 | 91 | 80 | 62 | 48 |
Income - Line of Business | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
Gross Profit: Clinical Services [... |
-- | 209 | 157 | -- | -- | -- |
Gross Profit: Advanced Diagnostic... |
-- | 36 | 31 | -- | -- | -- |
NFM - Operating & Non Financial Metrics | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
Clinical - Number of tests perfor... |
-- | 1,165,079 | 1,088,055 | 1,086,768 | 976,069 | 987,539 |
Clinical - Average revenue/test [... |
-- | -- | 0 | 0 | 0 | 0 |